Beijing, China

Yueying Jin

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Peking University. Active years: 2011-2016.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yueying Jin in Cancer Research

Introduction

Yueying Jin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer research through his innovative work on human cancer-related genes. With a total of 2 patents, his inventions aim to advance the development of new anti-cancer approaches and medicines.

Latest Patents

Yueying Jin's latest patents focus on the human cancer-related gene LAPTM4B and its encoded products. The inventions disclose various nucleotide sequences that are crucial for understanding cancer mechanisms. These sequences include SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, and SEQ ID No: 8. Additionally, the patents cover polynucleotides that encode specific protein sequences and DNA sequences with over 90% homology to the specified sequences. The implications of these inventions are profound, as they enable the development of new anti-cancer approaches and medicines, potentially creating a significant impact on human society.

Career Highlights

Yueying Jin is affiliated with Peking University, where he continues to engage in groundbreaking research. His work has positioned him as a key figure in the scientific community, particularly in the realm of cancer genetics.

Collaborations

Yueying Jin collaborates with notable colleagues, including Ye Zhang and Jingan Rui, who contribute to his research endeavors.

Conclusion

Yueying Jin's innovative work in cancer research exemplifies the potential of genetic studies to transform medical approaches to cancer treatment. His contributions are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…